Product NDC: | 49708-521 |
Proprietary Name: | Flumadine |
Non Proprietary Name: | flumadine |
Active Ingredient(s): | 100 mg/1 & nbsp; flumadine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49708-521 |
Labeler Name: | Caraco Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019649 |
Marketing Category: | NDA |
Start Marketing Date: | 20090922 |
Package NDC: | 49708-521-88 |
Package Description: | 100 TABLET in 1 BOTTLE (49708-521-88) |
NDC Code | 49708-521-88 |
Proprietary Name | Flumadine |
Package Description | 100 TABLET in 1 BOTTLE (49708-521-88) |
Product NDC | 49708-521 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | flumadine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090922 |
Marketing Category Name | NDA |
Labeler Name | Caraco Pharma, Inc. |
Substance Name | RIMANTADINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |